Skip to main content

stock

VBIO · Valion Bio, Inc.

What Valion Bio, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live VBIO price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on VBIO.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
22,189,739 as of 2026-08-13 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
-58.1%
Operating
—
Net
—

Returns

ROE
-441.6%
ROA
-57.7%

Health

Current ratio
1.1x
Debt/equity
—

Deep value

NCAV
-$17.21M
NCAV per share
-$0.78
Price/NCAV
Locked
NNWC
-$18.11M
NNWC per share
-$0.82
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30——-$6.42M-$7.10M
10-Q filed 2026-08-14
2026-03-31——-$5.63M-$6.20M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31——-$2.36M-$2.85M
10-K filed 2026-03-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$146,000-$145,000-$2.48M-$2.60M
10-Q filed 2025-11-14
2025-06-30$86,000$54,000-$1.68M-$1.93M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2025-03-31$70,000$50,000-$1.38M-$1.50M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$180,000-$239,000-$298,000-$1.48M
10-K filed 2026-03-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$126,000$44,000-$1.43M-$1.43M
10-Q filed 2025-11-14
Assets
$32.47M
Equity
$4.25M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$7.90M-$8.88M-$7.04M
2024-12-31$780,000-$4.48M-$5.66M-$5.72M
2023-12-31$1.18M-$8.24M-$8.24M-$8.63M
2022-12-31$1.84M-$10.10M-$10.10M-$8.93M
2021-12-31$1.26M-$5.63M-$8.49M—

Company filings

since Mon Dec 29 · 6 offering filings in 12 months

events

  • Other event

    Other event
    Oct 68-K
  • Other event

    Other event
    Oct 18-K
  • Executive or director change, Regulation FD disclosure

    Executive or director changeRegulation FD disclosure
    Sep 238-K
  • Material agreement, Unregistered share sale, Executive or director change, Regulation FD disclosure

    Material agreementUnregistered share saleExecutive or director changeRegulation FD disclosure
    Sep 18-K
  • Shareholder rights changed, Bylaws or fiscal year change, Regulation FD disclosure

    Shareholder rights changedBylaws or fiscal year changeRegulation FD disclosure
    Aug 278-K
  • Shareholder vote results

    Shareholder vote results
    Aug 208-K/A

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named VBIO, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about VBIO.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about VBIO.

nakagai

Signals on VBIO come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the VBIO board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Valion Bio, Inc. (VBIO): SEC filings, financials and insider trades · Nakagai